Brean Capital Raises Price Target on NuVasive (NUVA) Following 2Q EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
NuVasive Announces Definitive Settlement With United States
July 28, 2015 4:06 PM EDTSAN DIEGO, CA -- (Marketwired) -- 07/28/15 -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that it has reached a definitive settlement with the U.S. Department of Justice ("DOJ") related to the subpoena issued to the Company by the Office of Inspector General of the Department of Health and Human Services ("OIG") in 2013. NuVasive admits no wrongdoing as part of the settlement.
On April 29, 2015, the Company announced that it had reached an agreement in principle to settle the... More
NuVasive Reports Second Quarter 2015 Financial Results
July 28, 2015 4:05 PM EDTSAN DIEGO, CA -- (Marketwired) -- 07/28/15 -- Second Quarter 2015 Highlights:
Revenue increased 6.4% to $202.9 million, or 8.5% on a constant currency basis;Non-GAAP operating profit margin of 15.3%; GAAP operating profit margin of 12.7%; Adjusted EBITDA margin of 24.9%; Non-GAAP net income of $15.7 million; GAAP net income of $10.3 million;Non-GAAP earnings per share of $0.31; GAAP earnings per share of $0.20;... More